Related Experiment Videos
Chlamydia pneumoniae and cardiovascular disease
L A Campbell1, C C Kuo, J T Grayston
1Department of Pathobiology, University of Washington, Seattle 98195, USA. lacamp@u.washington.edu
Insights
Chlamydia pneumoniae infection is linked to cardiovascular diseases like atherosclerosis. Evidence shows the pathogen in arterial plaques, suggesting a role in disease development.
Area of Science:
- Infectious diseases
- Cardiovascular medicine
- Pathogen research
Background:
- Chlamydia pneumoniae is a common cause of respiratory illness.
- Emerging evidence links C. pneumoniae infection to atherosclerosis and related cardiovascular conditions.
- The pathogen has been detected in atherosclerotic lesions but not in healthy arteries.
Purpose of the Study:
- To review the association between Chlamydia pneumoniae and cardiovascular disease.
- To explore the potential role of chronic C. pneumoniae infection in atherosclerosis.
- To summarize current evidence on C. pneumoniae's involvement in cardiovascular pathology.
Main Methods:
- Review of seroepidemiologic studies associating C. pneumoniae antibodies with cardiovascular diseases.
- Analysis of studies detecting C. pneumoniae in human atherosclerotic lesions and plaques.
- Examination of findings from human intervention studies and animal models.
Main Results:
- Seroepidemiologic data consistently associate C. pneumoniae antibodies with coronary artery disease, myocardial infarction, and cerebrovascular disease.
- The presence of C. pneumoniae in atherosclerotic plaques and its absence in healthy tissue support its role.
- Ongoing research includes human intervention trials and animal models to clarify the pathogen's contribution.
Conclusions:
- Chlamydia pneumoniae is strongly associated with atherosclerosis and cardiovascular disease.
- The pathogen's presence in arterial lesions suggests a role in the initiation or progression of cardiovascular pathology.
- Further research is needed to fully elucidate the mechanisms and implications of C. pneumoniae infection in cardiovascular health.
Abstract:
Chlamydia pneumoniae is a ubiquitous pathogen that causes acute respiratory disease. The spectrum of C. pneumoniae infection has been extended to atherosclerosis and its clinical manifestations. Seroepidemiologic studies have associated C. pneumoniae antibody with coronary artery disease, myocardial infarction, carotid artery disease, and cerebrovascular disease. The association of C. pneumoniae with atherosclerosis is corroborated by the presence of the organism in atherosclerotic lesions throughout the arterial tree and the near absence of the organism in healthy arterial tissue. C. pneumoniae has also been isolated from coronary and carotid atheromatous plaques. To determine whether chronic infection plays a role in initiation or progression of disease, intervention studies in humans have been initiated, and animal models of C. pneumoniae infection have been developed. This review summarizes the evidence for the association and potential role of C. pneumoniae in cardiovascular disease.